semaglutide prescription requirements for diabetes patients first time visit Shares in Danish drugmaker Novo Nordisk soar on weight-loss drugs Ozempic and Wegovy Who Qualifies for Semaglutide GLP-1

GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)

Peptide Dosage: Storage & Handling Guide Protect your peptide dosage after reconstitution

For individuals with less fat, pinching the skin can help

Some may contain the wrong ingredient, too much active ingredient, too little active ingredient, or harmful contaminants

Policymakers should mandate coverage for GLP-1 products for both diabetes and obesity across public and private payers